BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Vanella S, Brisinda G, Marniga G, Crocco A, Bianco G, Maria G. Botulinum toxin for chronic anal fissure after biliopancreatic diversion for morbid obesity. World J Gastroenterol 2012; 18(10): 1021-1027 [PMID: 22416176 DOI: 10.3748/wjg.v18.i10.1021]
URL: https://www.wjgnet.com/1007-9327/full/v18/i10/1021.htm
Number Citing Articles
1
A. L. Pelletier, A. Boukris, S. Karunakaran, F. Dib, C. Laouénan, B. Hansel, K. Arapis, L. Abramowitz. A prospective study of anal symptoms and continence among obese patients before and after bariatric surgeryTechniques in Coloproctology 2020; 24(12): 1263 doi: 10.1007/s10151-020-02316-4
2
Noel Salgado-Nesme, Oscar Santes, Mario Trejo-Ávila, Jesús Morales-Maza, Tomás Patiño-Gómez, Danilo Solórzano-Vicuña, Omar Vergara-Fernández, Mauricio Sierra, Juan Pablo Pantoja. Incidence of benign anal diseases after bariatric surgeryObesity Medicine 2020; 20: 100306 doi: 10.1016/j.obmed.2020.100306
3
Adam Bobkiewicz, Wojciech Francuzik, Lukasz Krokowicz, Adam Studniarek, Witold Ledwosiński, Jacek Paszkowski, Michal Drews, Tomasz Banasiewicz. Botulinum Toxin Injection for Treatment of Chronic Anal Fissure: Is There Any Dose‐Dependent Efficiency? A Meta‐AnalysisWorld Journal of Surgery 2016; 40(12): 3064 doi: 10.1007/s00268-016-3693-9
4
O. Cano‐Valderrama, A. Sánchez‐Pernaute, M. A. Rubio, P. Talavera, E. Martín‐Antona, A. J. Torres. Incidence of new‐onset benign anal disorders after bariatric surgeryClinical Obesity 2018; 8(1): 50 doi: 10.1111/cob.12228
5
H.-L. Chen, X.-B. Woo, H.-S. Wang, Y.-J. Lin, H.-X. Luo, Y.-H. Chen, C.-Q. Chen, J.-S. Peng. Botulinum toxin injection versus lateral internal sphincterotomy for chronic anal fissure: a meta-analysis of randomized control trialsTechniques in Coloproctology 2014; 18(8): 693 doi: 10.1007/s10151-014-1121-4